Sodium glucose cotransporter-2 inhibitor treatment and the risk of diabetic ketoacidosis in Denmark: A retrospective cohort study of five years of use.
CONCLUSION: We observed no significant increase in risk of DKA for SGLT2i users compared to GLP1-RA. However, a significantly higher IR of DKA was observed with concomitant insulin use, and the risk of DKA was considerably higher for the SGLT2 group using insulin.
PMID: 32814538 [PubMed - as supplied by publisher]
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Laursen HVB, Røikjer JB, Dal J, Jensen MH Tags: Curr Drug Saf Source Type: research
More News: Denmark Health | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Insulin | SGLT2 Inhibitors | Sodium | Statistics | Study